Global Head Drug Product Development & Technology

In this newly created role, you will lead the global Drug Product (DP) Development organization and further strengthen Siegfried’s pharmaceutical development capabilities. You will drive the advancement of Siegfried’s DP technologies and development project performance across all clinical phases. You will ensure best-in-class pharmaceutical R&D processes covering multiple dosage forms, including oral solid dosage forms, parenterals, inhalables, and ophthalmics. The role includes evaluating new customer development requests for formulation and process development, overseeing execution of development programs, and ensuring successful transfer to GMP manufacturing. In addition, you will build and expand the organization’s capabilities by attracting, developing, and mentoring top DP development talent across sites.

Founded in 1873 in Zofingen, Switzerland, Siegfried has grown into a global network of 13 sites across three continents. With a team of more than 3,800 highly skilled professionals, we take the innovations of our pharmaceutical customers to industrial scale and manufacture safe drugs for patients worldwide. As a fully integrated CDMO, Siegfried is one of the few organizations today that can carry out the development and manufacturing of APIs and finished dosage forms under one roof. This unique combination of know-how and experience makes us the most trusted partner in the pharmaceutical industry.

• Pharmacist or equivalent scientific background; PhD in Pharmaceutical Technology preferred

• Deep expertise in oral solid dosage form (OSD) and parenteral development is essential, including experience with complex formulations (e.g., BCS Class II/III compounds, amorphous solid dispersions)

• Proven track record of advancing OSD and/or parenteral programs from early development through clinical phases to commercialization

• Strong understanding of analytical characterization and CMC development for OSD and parenteral dosage forms

• Working knowledge and/or strategic oversight of additional dosage forms (e.g., inhalation, ophthalmic) is advantageous

• Deep expertise in CMC development, preferably within Drug Product Development

• With demonstrated track record advancing development programs from early research through clinical development and product launch

• Experience contributing to or generating Drug Product intellectual property

• Strong academic network and experience with public-private collaborations

• Proven ability to build and lead global teams across multiple sites

• Strong cross-cultural leadership and global mindset

• Experience working effectively in complex matrix organizations

• Ability to influence stakeholders in multi-site environments with indirect reporting structures